Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec 15;202(12):1622-1624.
doi: 10.1164/rccm.202007-2805ED.

Opportunities for Cardiovascular Benefits in Treating Obstructive Sleep Apnea in the Secondary Prevention Scenario

Diego R Mazzotti  1 , Luciano F Drager  2   3
Affiliations
Editorial

Opportunities for Cardiovascular Benefits in Treating Obstructive Sleep Apnea in the Secondary Prevention Scenario

Diego R Mazzotti et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cardiovascular (CV) benefits in treating obstructive sleep apnea (OSA) and potential windows of opportunities (patients’ profile, biomarkers, etc.). (A) Standard (one-size-fits-all) approach. (B) Personalized approach. Green boxes represent favorable CV effects and blue boxes neutral CV effects. *Current evidence based on observational studies. **Ceiling effect: Under multiple comorbidities, OSA may not represent an independent risk factor, and CPAP therapy therefore would not provide additional CV benefits. Specific and predictive biomarkers for OSA are currently unavailable in clinical practice. Other benefits beyond CV diseases are not considered here yet have major importance in OSA treatment. AHI = apnea–hypopnea index; CPAP = continuous positive airway pressure.
See this image and copyright information in PMC

Comment on

  • The Effect of Sleep Apnea on Cardiovascular Events in Different Acute Coronary Syndrome Phenotypes.
    Zapater A, Sánchez-de-la-Torre M, Benítez ID, Targa A, Bertran S, Torres G, Aldomà A, De Batlle J, Abad J, Duran-Cantolla J, Cabriada-Nuño V, Mediano O, Masdeu MJ, Muñoz C, Masa JF, De la Peña M, Mayos M, Coloma R, Montserrat JM, Chiner E, Mínguez O, Pascual L, Cortijo A, Martínez D, Dalmases M, McEvoy RD, Barbé F, Sánchez-de-la-Torre A; Spanish Sleep Network. Zapater A, et al. Am J Respir Crit Care Med. 2020 Dec 15;202(12):1698-1706. doi: 10.1164/rccm.202004-1127OC. Am J Respir Crit Care Med. 2020. PMID: 32648771

References

    1. Drager LF, McEvoy RD, Barbe F, Lorenzi-Filho G, Redline S INCOSACT Initiative (International Collaboration of Sleep Apnea Cardiovascular Trialists) Sleep apnea and cardiovascular disease: lessons from recent trials and need for team science. Circulation. 2017;136:1840–1850. - PMC - PubMed
    1. Rosen L, Manor O, Engelhard D, Zucker D. In defense of the randomized controlled trial for health promotion research. Am J Public Health. 2006;96:1181–1186. - PMC - PubMed
    1. Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–1053. - PubMed
    1. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med. 2012;156:115–122. - PubMed
    1. Martínez-García MA, Campos-Rodríguez F, Catalán-Serra P, Soler-Cataluña JJ, Almeida-Gonzalez C, De la Cruz Morón I, et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med. 2012;186:909–916. - PubMed